
Cabaletta Bio’s CEO to Take the Stage at 42nd Annual J.P. Morgan Healthcare Conference
PHILADELPHIA, PA — Cabaletta Bio, Inc., a clinical-stage biotechnology company listed on NASDAQ (CABA), is set to make its mark at the 42nd Annual J.P. Morgan Healthcare Conference. The company …
Cabaletta Bio’s CEO to Take the Stage at 42nd Annual J.P. Morgan Healthcare Conference Read More